PORTFOLIO

LightOx

Light activated chemotherapy platform for the treatment of early-stage mouth cancers

Platform / Therapeutic

Active

Abselion

Biologic quantification provided at the benchtop using electrochemical detection

Tools

Active

Cellesce (acquired by Molecular Devices)

Bioprocess for scaling patient derived organoids for use in high throughput screening

Tools

Acquired

Bastion Therapeutics

Proprietary GRIT platform technology to engineer Tregs to overcome challenges associated with previous generations of Treg cell therapies

Platform / Therapeutic

Active

Mesenbio

Extracellular vesicle platform developing novel therapeutics to regenerate tissue in autoimmune diseases

Platform / Therapeutic

Active

Stealth Biotech

First-in-class therapeutic targeting novel circulating factor

Therapeutic

Stealth

Stealth Biotech

First-in-class therapeutics utilising cell depletion approaches for autoimmune and immune mediated inflammatory disorders

Therapeutic

Stealth

Stealth Biotech

First-in-class therapeutic targeting novel metabolite transport

Therapeutic

Stealth